C. Charles-schoeman, M. Buch, G. Burmester, J. Liu, D. Dilley, H. Palac, S. Strengholt, B. Combe, J. Curtis
{"title":"动脉粥样硬化性心血管疾病风险对接受奥达帕替尼治疗的患者和比较者的影响:类风湿关节炎 SELECT 计划的事后分析","authors":"C. Charles-schoeman, M. Buch, G. Burmester, J. Liu, D. Dilley, H. Palac, S. Strengholt, B. Combe, J. Curtis","doi":"10.1016/j.rhum.2023.10.176","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":21450,"journal":{"name":"Revue du Rhumatisme","volume":"41 11","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact du risque de maladie cardiovasculaire athérosclérotique chez les patients traités par upadacitinib versus comparateurs : analyse post-hoc du programme SELECT dans la polyarthrite rhumatoïde\",\"authors\":\"C. Charles-schoeman, M. Buch, G. Burmester, J. Liu, D. Dilley, H. Palac, S. Strengholt, B. Combe, J. Curtis\",\"doi\":\"10.1016/j.rhum.2023.10.176\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":21450,\"journal\":{\"name\":\"Revue du Rhumatisme\",\"volume\":\"41 11\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revue du Rhumatisme\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.rhum.2023.10.176\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue du Rhumatisme","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.rhum.2023.10.176","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Impact du risque de maladie cardiovasculaire athérosclérotique chez les patients traités par upadacitinib versus comparateurs : analyse post-hoc du programme SELECT dans la polyarthrite rhumatoïde